Evaluation of the biological effects of atorvastatin in lung transplant recipients

F. Meloni, A. M. Fietta, N. Solari, M. Morosini, E. Pozzi (Pavia, Italy)

Source: Annual Congress 2007 - New insights into clinical lung transplantation
Session: New insights into clinical lung transplantation
Session type: Electronic Poster Discussion
Number: 324
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Meloni, A. M. Fietta, N. Solari, M. Morosini, E. Pozzi (Pavia, Italy). Evaluation of the biological effects of atorvastatin in lung transplant recipients. Eur Respir J 2007; 30: Suppl. 51, 324

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Impact of antifibrotic drugs in lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Airway cellular response to two different immunosuppressive regimens in lung transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 466s
Year: 2004

Microbiological impact of regular colistin use in a population of lung transplant recipients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Pre-habilitation in lung transplant candidates
Source: Short video discussion 2021
Year: 2021

The effects of dyspnoea in lung transplant candidates
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017


Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008


Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018


Impact of pulmonary hypertension after lung transplantation on functional outcome
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010

Fatigue and functional capacity in kidney transplant recipients before and after transplant.
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017


The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020

Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients
Source: Eur Respir J 2007; 30: Suppl. 51, 176s
Year: 2007

Short and mid-term outcomes of lung transplant recipients with COVID-19
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021


Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016